Volume 133, Issue 1, Pages (July 2007)

Slides:



Advertisements
Similar presentations
Abnormal Liver Tests and Fatty Liver on Ultrasound
Advertisements

Volume 148, Issue 4, Pages (April 2015)
Flavia D. Mendes, Ayako Suzuki, Schuyler O. Sanderson, Keith D
Acute hepatitis induced by greater celandine (Chelidonium majus)
Volume 145, Issue 1, Pages (July 2013)
Les Lang  Gastroenterology  Volume 133, Issue 1, (July 2007)
Les Lang  Gastroenterology  Volume 133, Issue 1, (July 2007)
Volume 144, Issue 5, Pages (May 2013)
Steatosis Is a Cofactor in Liver Injury in Hemochromatosis
NAFLD, Obesity, and Bariatric Surgery
Is HCV Infection a Neurologic Disorder?
Outcomes Among Living Liver Donors
Ira J. Fox, Stephen C. Strom  Gastroenterology 
Volume 149, Issue 2, Pages (August 2015)
Gastroenterology 2011–2016: Looking Back and Forward
Stephen A. Harrison, MD, FACP  Clinical Gastroenterology and Hepatology 
Volume 128, Issue 7, Pages (June 2005)
Targeting the FXR Nuclear Receptor to Treat Liver Disease
The Changing Liver Transplant Waitlist: An Emerging Liver Purgatory?
Unusual Case of an Upset Stomach
Volume 139, Issue 1, Pages (July 2010)
Volume 135, Issue 4, Pages (October 2008)
A Historical Perspective on Clinical Advances in Pancreatic Diseases
Volume 150, Issue 4, Pages (April 2016)
Volume 137, Issue 2, Pages (August 2009)
Abstracts from Around the World
Volume 149, Issue 2, Pages (August 2015)
Assessment of Fibrosis by Transient Elastography Compared With Liver Biopsy and Morphometry in Chronic Liver Diseases  Grace Lai–Hung Wong, Vincent Wai–Sun.
Volume 141, Issue 5, Pages e9 (November 2011)
Noninvasive Assessment of Nonalcoholic Fatty Liver Disease in Obese or Overweight Patients  Sven M.A. Francque, An Verrijken, Ilse Mertens, Guy Hubens,
Adequacy of Endoscopic Ultrasound Core Needle Biopsy Specimen of Nonmalignant Hepatic Parenchymal Disease  Ferga C. Gleeson, Amy C. Clayton, Lizhi Zhang,
Michael J. Williams, Andrew D. Clouston, Stuart J. Forbes 
Michel I. Kafrouni, Robert A. Anders, Sumita Verma 
Volume 155, Issue 6, Pages (December 2018)
Abnormal Liver Tests and Fatty Liver on Ultrasound
Mallory–Denk Bodies Are Associated With Outcomes and Histologic Features in Patients With Chronic Hepatitis C  Mina O. Rakoski, Morton B. Brown, Robert.
Volume 136, Issue 1, Pages (January 2009)
Rafael Esteban, Maria Buti  Gastroenterology 
Volume 128, Issue 1, Pages (January 2005)
Volume 150, Issue 3, Pages (March 2016)
Reduced Mortality Rates Following Elective Percutaneous Liver Biopsies
Volume 139, Issue 1, Pages e2 (July 2010)
Volume 133, Issue 2, Pages (August 2007)
Volume 150, Issue 7, Pages (June 2016)
Volume 132, Issue 2, (February 2007)
AGA technical review on nonalcoholic fatty liver disease
Ashwin N. Ananthakrishnan, David Lieberman  Gastroenterology 
Volume 132, Issue 3, Pages (March 2007)
Volume 135, Issue 6, Pages e2 (December 2008)
Volume 142, Issue 7, Pages e2 (June 2012)
Covering the Cover Gastroenterology
The Dawning of a New Editorial Board for Gastroenterology
Volume 141, Issue 4, Pages (October 2011)
Volume 149, Issue 6, Pages (November 2015)
Volume 140, Issue 1, Pages (January 2011)
Volume 142, Issue 4, Pages e6 (April 2012)
Baby-Epsilon Steps Toward the Triple Aim
Issue Highlights Clinical Gastroenterology and Hepatology
Volume 142, Issue 6, Pages e4 (May 2012)
Changing of the Guards: 2011–2016 Gastroenterology Team
Volume 135, Issue 1, Pages (July 2008)
Volume 139, Issue 6, Pages e1 (December 2010)
Trunk Fat as a Determinant of Liver Disease
Volume 138, Issue 6, Pages (May 2010)
End-Stage Liver Disease in 2008: Finally a Glass Half Full
American Gastroenterological Association (AGA) Institute Technical Review on the Diagnosis and Management of Celiac Disease  Alaa Rostom, Joseph A. Murray,
Fulminant Hepatic Failure Secondary to Erlotinib
Controversies in Liver Transplantation for Hepatitis C
Top left—haematoxylin van Gieson (HvG) stain showing mild zone 3 steatosis without fibrosis, in which collagen fibres (pink–red, arrow) are confined to.
Volume 135, Issue 6, Pages (December 2008)
Presentation transcript:

Volume 133, Issue 1, Pages 80-90 (July 2007) Progressive Fibrosis in Nonalcoholic Steatohepatitis: Association With Altered Regeneration and a Ductular Reaction  Michelle M. Richardson, Julie R. Jonsson, Elizabeth E. Powell, Elizabeth M. Brunt, Brent A. Neuschwander–Tetri, Prithi S. Bhathal, John B. Dixon, Martin D. Weltman, Herbert Tilg, Alexander R. Moschen, David M. Purdie, Anthony J. Demetris, Andrew D. Clouston  Gastroenterology  Volume 133, Issue 1, Pages 80-90 (July 2007) DOI: 10.1053/j.gastro.2007.05.012 Copyright © 2007 AGA Institute Terms and Conditions

Figure 1 Ductular reaction in NASH. (A) Periportal ductular reaction in NASH, stage 3, with bridging fibrosis. (B) CK7 staining of single putative progenitor cells, canals of Hering, and ductular structures. The ductules are seen at the bottom of the picture. (C) Normal liver. (D) Simple steatosis with no significant ductular reaction. (E) NASH cirrhosis. Biopsy specimens with advanced-stage fibrosis showed the most extensive DR. CK7 immunoperoxidase original magnifications: (A) 100×; (B) 400×; (C and D) 200×; and (E) 100×. Gastroenterology 2007 133, 80-90DOI: (10.1053/j.gastro.2007.05.012) Copyright © 2007 AGA Institute Terms and Conditions

Figure 2 There is a highly significant correlation between the expansion of HPCs and the extent of DR (r = 0.582, P < .0001). pt, portal tract. Gastroenterology 2007 133, 80-90DOI: (10.1053/j.gastro.2007.05.012) Copyright © 2007 AGA Institute Terms and Conditions

Figure 3 (A–F) The relationship between the expansion of HPCs and the extent of ductular reaction according to type and stage of NAFLD. Expansion of HPCs can be seen in (B–E) all types of NAFLD compared with (A) nondiseased liver, but an extensive DR is seen mainly in NASH patients with (D and F) portal and linking fibrosis. **P < .01, ***P < .001. As a visual aid, dotted lines enclose the extent of DR and HPCs for nondiseased liver. Gastroenterology 2007 133, 80-90DOI: (10.1053/j.gastro.2007.05.012) Copyright © 2007 AGA Institute Terms and Conditions

Figure 4 The extent of DR increases with stage of fibrosis. *P < .05, **P < .01, ***P < .001. Gastroenterology 2007 133, 80-90DOI: (10.1053/j.gastro.2007.05.012) Copyright © 2007 AGA Institute Terms and Conditions

Figure 5 Increased replicative arrest of hepatocytes (p21 index) is associated with a more extensive periportal DR. *P < .05, **P < .01. Gastroenterology 2007 133, 80-90DOI: (10.1053/j.gastro.2007.05.012) Copyright © 2007 AGA Institute Terms and Conditions

Figure 6 Increased replicative arrest of hepatocytes (p21 index) is associated with increased insulin resistance as assessed by HOMA-IR. **P < .01 compared with no replicative arrest. Gastroenterology 2007 133, 80-90DOI: (10.1053/j.gastro.2007.05.012) Copyright © 2007 AGA Institute Terms and Conditions

Figure 7 Increased replicative arrest of hepatocytes (p21 index) is seen in patients with NASH compared with steatosis alone. **P < .01, ***P < .001 compared with steatosis only. Gastroenterology 2007 133, 80-90DOI: (10.1053/j.gastro.2007.05.012) Copyright © 2007 AGA Institute Terms and Conditions